Government Affairs
Refine search
Biotechnology
UK government-backed Cell and Gene Therapy Catapult (CGT Catapult), a tech and innovation organization specializing in the advancement of the cell and gene therapy industry, has appointed Ed Samuel as its chief operations officer (COO). 23 July 2025
Pharmaceutical
The Dutch Ministry of Economic Affairs (EZ) has presented an ambitious action plan to increase public and private investment in research and development (R&D) to 3% of gross domestic product. 21 July 2025
Pharmaceutical
The UK government’s new life sciences plan has been met with skepticism by the pharmaceutical industry, which says the strategy will fall flat unless there is a serious shift in the way new medicines are funded and valued. 16 July 2025
Pharmaceutical
On Tuesday, the day new global data reveal that childhood vaccine coverage has stalled and deadly disease outbreaks are accelerating, nearly 400 scientists, faith leaders, and health advocates are demanding that the US Senate take action to stop what they call Health Secretary Robert F Kennedy Jr’s “systematic assault” on global immunization. 16 July 2025
Pharmaceutical
In the USA, the 340B hospital markup program cost state and federal taxpayers an estimated $6.5 billion per year due to lost Medicaid rebates, according to a new report from Berkeley Research Group (BRG). 15 July 2025
Pharmaceutical
The US Food and Drug Administration (FDA) last week authorized KalVista Pharmaceutical’s Ekterly for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older. US President Donald Trump put out another warning on imposing tariffs on pharmaceutical products, albeit they may get a grace period of 10 months. US biopharma Rhythm Pharmaceuticals released encouraging Phase II results for its bivamelagon in acquired hypothalamic obesity. Also of note, AbbVie entered an up to $1.9 billion licensing deal with Ichnos Glenmark on autoimmune diseases. 13 July 2025
Pharmaceutical
The US Supreme Court has aided President Donald Trump in his mission to plough on with a major workforce reduction and agency overhaul impacting the US Department of Health and Human Services (HHS). 10 July 2025
Pharmaceutical
Donald Trump has escalated his warnings to the pharmaceutical industry with a pledge to introduce import tariffs as high as 200% on drugs produced outside the USA. The US president said companies would be granted a grace period of up to 18 months before the measure takes effect. 9 July 2025
Pharmaceutical
Last week’s announcement of a Life Science Strategy from the European Commission, includes action to address long-standing issues that have been hampering the region’s competitiveness and preventing European patients from accessing the latest advances in treatment. The Strategy represents a very welcome step forward for life science companies operating in Europe. 7 July 2025
Pharmaceutical
A Dutch appeals court has ruled that health insurers acted unlawfully in their group tender for three CDK 4/6 inhibitors, reigniting debate over cost-driven drug policies in the Netherlands. The case centered on whether insurers can restrict prescribing choices for innovative cancer drugs that differ in clinical profiles. 7 July 2025
Pharmaceutical
The UK government today launched its 10 Year Health Plan for the National Health Service (NHS), promising a "new era." A new network of neighborhood health hubs will be set up to shift care out of hospitals and into the community. 3 July 2025
Pharmaceutical
A Republican-backed amendment to the sweeping budget proposal championed by US president Donald Trump would sharply reduce Medicaid spending, targeting one of the core features of the Affordable Care Act. 1 July 2025
Pharmaceutical
As pressure builds around drug pricing and access, US trade group PhRMA is pushing back against criticism of pharmaceutical patents. In a recent blog post, the organization argued that intellectual property protections are essential to biopharmaceutical innovation and key to sustaining the American economy. 1 July 2025
Pharmaceutical
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has appointed Bayer’s Stefan Oelrich as its new president, with Roche chief executive Teresa Graham and Almirall’s Carlos Gallardo taking on first and second vice president roles. 30 June 2025
Pharmaceutical
Despite calls for the meeting to be delayed, Wednesday’s meeting of the Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) went ahead. 27 June 2025
Generics
Israeli generics major Teva Pharmaceutical Industries has highlighted that Europe is experiencing increasing pressure on its medicines supply. 25 June 2025
Pharmaceutical
Republican Senator Bill Cassidy has called for Wednesday’s meeting of the Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) to be delayed. 25 June 2025
Pharmaceutical
The UK government has unveiled a sweeping industrial strategy aimed at catapulting the country into the top tier of global life sciences economies by 2035. Positioned as one of eight growth sectors, life sciences is set to benefit from a multibillion-dollar push to streamline regulation, enhance health data infrastructure, and accelerate innovation. 25 June 2025
Pharmaceutical
Health and Human Services Secretary Robert F Kennedy Jr came under heavy scrutiny from Democratic lawmakers during a heated budget hearing on Capitol Hill, as concerns mounted over his handling of vaccine policy, sweeping agency cuts, and what some members described as a disregard for transparency and scientific integrity. 25 June 2025
Pharmaceutical
See-sawing global tariffs, a US regulator in flux and a possible end to US drug price premia are not, apparently, enough to stymie pharmaceutical industry growth. 24 June 2025
Pharmaceutical
Fewer new innovative medicines, and in fact with a delay of almost two years from their approval by the European Medicines Agency (EMA), are coming to Greece, as demonstrated by the Association of Pharmaceutical Companies of Greece (SFEE) in a press conference held to present two studies concerning Greek patients' access to new, innovative treatments. 1 June 2026
Pharmaceutical
The Pharmaceutical Research and Manufacturers of America has used National Cancer Research Month to argue that US cancer research leadership could weaken if pricing and reimbursement policies reduce incentives for drug development. 29 May 2026
Pharmaceutical
The European Parliament and European Union (EU) member states have reached a provisional agreement on the Critical Medicines Act (CMA), a major legislative initiative designed to strengthen medicine supply chains and reduce dependence on overseas manufacturing. 22 May 2026
Pharmaceutical
Jeffery Taubenberger, the acting director of the US National Institute of Allergy and Infectious Diseases (NIAID), has stepped down from the role, according to reports citing congressional Democrats and sources familiar with the matter. 22 May 2026
Biotechnology
A new national framework designed to strengthen the delivery of advanced therapy clinical trials across the UK has been launched by the Advanced Therapy Treatment Centre (ATTC) network, as the country seeks to reinforce its position in the fast-growing cell and gene therapy sector. 20 May 2026
Pharmaceutical
Northern Ireland’s life sciences industry is set to benefit from closer collaboration with the UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), it was announced Wednesday. 14 May 2026
Pharmaceutical
India has once again been placed on the Priority Watch List in the 2026 Special 301 Report released by the Office of the United States Trade Representative (USTR). 13 May 2026
Pharmaceutical
The Wall Street Journal Editorial Board is once again raising concerns about the USA’s federal 340B drug pricing program – this time questioning whether the program is benefiting patients at all. 12 May 2026
Pharmaceutical
For the first time, Swedish pharma trade group Lif launched its own program track at Vitalis. Together with the Swedish Medical Products Agency, SweTrial and Swedish Medtech, the focus was on how Sweden can strengthen its position as an attractive clinical trial country. 11 May 2026
Biosimilars
Industry group Medicines for Europe has urged policymakers to strengthen support for biosimilar medicines, arguing that wider uptake could improve patient access to biologic therapies while reinforcing Europe’s pharmaceutical resilience. 7 May 2026
Pharmaceutical
The US Centers for Medicare & Medicaid Services (CMS) will provide eligible Medicare beneficiaries access to certain GLP-1 medications for $50 per month beginning July 1, 2026, through December 31, 2027. 7 May 2026
Pharmaceutical
As Europe strives to compete globally in life sciences, predictable and robust IP incentives will determine whether tomorrow’s breakthroughs are developed here or elsewhere, says the European Federation of Pharmaceutical Industries and Associations (EFPIA). 27 April 2026
Pharmaceutical
India’s Central Drugs Standard Control Organization (CDSCO) and Brazil’s National Health Surveillance Agency (ANVISA), have established a framework to align regulatory practices. 27 April 2026
Pharmaceutical
Among significant news last week, Denmark’s Novo Nordisk presented positive results for its sickle cell disease candidate etavopivat. Eli Lilly revealed an up to $7 billion deal to acquire Kelonia Therapeutics and its gene therapy KLN-1010. The US Centers for Medicaid and Medicare Services (CMS) has extended the GLP-1 Bridge program for obesity medicines as insurers hold back. US biopharma Grace Therapeutics suffered a setback as the US Food and Drug Administration (FDA) issued a complete response letter (CRL) on the company’s new drug application (NDA) for GTx-104, which is being developed for aneurysmal subarachnoid hemorrhage (aSAH). 26 April 2026
Pharmaceutical
German family-owned pharma major Boehringer Ingelheim’s Indian subsidiary and India’s National Institute of Pharmaceutical Education and Research (NIPER) have signed a five year memorandum of understanding (MoU) to advance pharmaceutical research, education, and innovation in eastern India. 25 April 2026
Biotechnology
Over the decades, Germany’s Bayer has played as big a part as any company in the discovery and development of innovative medicines to treat patients around the world. 24 April 2026
Pharmaceutical
The US government is set to bear the financial burden of covering blockbuster obesity medicines for Medicare beneficiaries, after private insurers balked at participating in a planned long-term payment model. 22 April 2026
Pharmaceutical
As US states debate new proposals to regulate prescription drug prices - such as prescription drug boards or referencing federal or foreign pricing - it’s critical to examine the real-world consequences of government-set prices. 22 April 2026
Pharmaceutical
Russia plans to increase public procurements of anti-cancer drugs that will be part of a new national project, which aims to ensure two-thirds of cancer patients survive five years or more after diagnosis with cancer by 2030, reports The Pharma Letter’s local correspondent. 20 April 2026
Pharmaceutical
Swiss industry group Interpharma has called for the country to maintain and expand its bilateral framework with the European Union, warning that political proposals affecting migration could disrupt the pharmaceutical sector. 20 April 2026
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A clinical-stage biotechnology company developing disease-modifying treatments for neurodegenerative diseases, with a primary focus on amyotrophic lateral sclerosis (ALS) and broader neurodegenerative biology. Neurizon aims to advance its lead small-molecule candidate into pivotal clinical testing and position it for regulatory evaluation and eventual patient access.
Copyright © The Pharma Letter 2026
| Headless Content Management with Blaze